Effect of tocilizumab on interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA)

Naotatsu Otsuji(Dokkyo Medical University Saitama Medical Center), Yasutsugu Fukushima(Dokkyo Medical University Saitama Medical Center), Kumiya Sugiyama(Beth Israel Deaconess Medical Center), Hirokuni Hirata(Dokkyo Medical University Saitama Medical Center), Hajime Arifuku(Dokkyo Medical University Saitama Medical Center), Tomoshige Wakayama(Dokkyo Medical University Saitama Medical Center), Kentaro Nakano(University of Tsukuba), Hiroyoshi Watanabe(Tokushima University), Kenya Koyama(Dokkyo Medical University Saitama Medical Center)
Unknown
September 7, 2020
Cited by 8


Related Papers